Trials / Completed
CompletedNCT00249730
Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.
A Prospective Multicenter, Parallel Group Study With A Single Blind Phase And A Double Blind Randomised Phase, To Evaluate The Efficacy And Satisfaction Of Viagra (Sildenafil Citrate) High Dose (100mg) Titration Compared With 50mg Dose, In Men With Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 510 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of Viagra dose titration to 100mg versus 50mg in men with erectile dysfunction, based on responses to the IIEF questionnaire as measured at the beginning and at the end of double blind treatment, comparing the group titrated to 100mg vs. the group maintained on 50mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil |
Timeline
- Start date
- 2005-10-01
- First posted
- 2005-11-07
- Last updated
- 2021-02-01
Locations
39 sites across 8 countries: Canada, France, Greece, Israel, Italy, Russia, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00249730. Inclusion in this directory is not an endorsement.